2-(4-bromophenyl)-1H-benzimidazole

We are 2-(4-bromophenyl)-1H-benzimidazole CAS:2622-74-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-(4-bromophenyl)-1H-benzimidazole
CAS.NO:2622-74-4
Synonyms:BPBMZ
2-(4-Bromophenyl)benzimidazole
Molecular Formula:C13H9BrN2
Molecular Weight:273.12800
 
Physical and Chemical Properties:
Density:1.546
Melting point:299ºC
Boiling point:435ºC
Flash point:216.9ºC
Index of Refraction:1.708
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

2-(4-bromophenyl)-1H-benzimidazole


Related News: Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.4-Amino-3-fluorophenol The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.Ethyl 4,6-dichloropyridazine-3-carboxylate The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 2-bromo-3-fluoropiridina CAS:40273-45-8 In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.

Related Products
Product Name
5-Ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine View Details
2-Chloro-3-nitropyridine View Details
Methyl Methoxyacetate View Details
2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane manufacturer acetohydrazide manufacturer 2-bromo-9,9-dimethyl-10-phenyl-9,10-dihydroacridine manufacturer N-[3-(Trimethoxysilyl)propyl]ethylenediamine manufacturer 2,2′,4,4′-Tetrahydroxybenzophenone manufacturer